NovelStem International Corp. (NSTM)
- Previous Close
0.0600 - Open
0.0600 - Bid --
- Ask --
- Day's Range
0.0600 - 0.0600 - 52 Week Range
0.0600 - 0.2800 - Volume
200 - Avg. Volume
891 - Market Cap (intraday)
2.813M - Beta (5Y Monthly) 0.19
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0900 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 2, 2018
- 1y Target Est
--
NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is based in Boca Raton, Florida.
www.novelstem.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NSTM
Performance Overview: NSTM
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NSTM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NSTM
Valuation Measures
Market Cap
2.81M
Enterprise Value
6.33M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
234.41
Price/Book (mrq)
--
Enterprise Value/Revenue
527.87
Enterprise Value/EBITDA
-1.67
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-17.98%
Return on Equity (ttm)
--
Revenue (ttm)
12k
Net Income Avi to Common (ttm)
-4.19M
Diluted EPS (ttm)
-0.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
53.06k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-116.67k
Company Insights: NSTM
NSTM does not have Company Insights